The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine

Published:2017-09 Issue:4 Volume:490 Page:1176-1182
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Cheon Ji Hyun,Kim Kyeong Seok,Yadav Dharmendra Kumar,Kim Mihyun,Kim Hyung Sik,Yoon Sungpil

Funder

National Research Foundation of Korea (NRF)

Korean goverment

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference28 articles.

1. Microtubules as a target for anticancer drugs;Jordan;Nat. Rev. Cancer,2004

2. Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer;Yang;Curr. Drug Targets,2010

3. Prediction of chemotherapy response with platinum and taxane in the advanced stage of ovarian and uterine carcinosarcoma: a clinical implication of in vitro drug resistance assay;Matsuo;Am. J. Clin. Oncol.,2010

4. Taxanes, microtubules and chemoresistant breast cancer;McGrogan;Biochim. Biophys. Acta,2008

5. Controversies in the management of adjuvant breast cancer with taxanes: review of the current literature;Araque Arroyo;Cancer Treat. Rev.,2011

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer;Frontiers in Oncology;2024-04-18

2. Co-treatment With Aripiprazole and Vincristine Sensitizes P-Glycoprotein-Overexpressing Drug-resistant MCF-7/ADR Breast Cancer Cells;Anticancer Research;2024-02-29

3. A Novel 3-meta-Pyridine-1,2,4-oxadiazole Derivative of Glycyrrhetinic Acid as a Safe and Promising Candidate for Overcoming P-Glycoprotein-Mediated Multidrug Resistance in Tumor Cells;ACS Omega;2023-12-12

4. Low-dose Pimecrolimus, an FDA-approved Calcineurin Inhibitor, Sensitizes Drug-resistant Cancer CellsviaStrong P-gp Inhibition;Anticancer Research;2023-02-28

5. Role of natural P-gp inhibitor in the effective delivery for chemotherapeutic agents;Journal of Cancer Research and Clinical Oncology;2022-10-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3